DETERMINATION OF TIMING OF CHEMOTHERAPY DELIVERY

• US 20120303284A1
• Filed: 11/01/2010
• Published: 11/29/2012
• Est. Priority Date: 12/17/2009
• Status: Abandoned Application

• Current Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Original Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Inventors: Markovic, Svetomir N., Leontovich, Alexey A., Ivanov, Leonid V.
• Application Number:
  US13/515,915
• Publication Number:
  US 20120303284A1
• Time in Patent Office: Days
• US Class Current: 702/19
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders

Abstract

A system and method for determination of one or more favorable time(s) for chemotherapy or other pharmacological treatment delivery analyze time-dependent fluctuations of at least one biological variable measured in blood samples obtained from clinical patients and determine one or more favorable times for the pharmacological treatment of the patient. In some examples, the biological variables are immune variables.

Claims

1. A method comprising:

receiving time series data of immune variable concentration for an observed time period for each of a plurality of identified immune variables;

fitting a periodic function to the time series data corresponding to each of the plurality of identified immune variables;

calculating a treatment prediction parameter based on a relative concentration and a relative differential of the fitted periodic function for each time series data that fits a periodic function;

choosing the proposed treatment date such that the treatment prediction parameter is maximized; and

reporting the proposed date of treatment that maximizes the treatment prediction parameter.

2. The method of claim 1 further comprising:

determining a relative concentration of the fitted periodic function based on a maximum immune variable concentration within the observed time period, a minimum immune variable concentration within the observed time period, and an extrapolated immune variable concentration on a proposed treatment date;

determining a relative derivative of the fitted periodic function based on a maximum derivative within the observed time period, a minimum derivative within the same period, and an extrapolated derivative on the proposed treatment date;

3. The method of claim 1, wherein fitting a periodic function to the time series data comprises fitting each set of time series data to a cosine function.

4. The method of claim 1 wherein receiving time series data of immune variable concentration for an observed time period for each of a plurality of identified immune variables comprises receiving time series data of immune variable concentration for an observed time period for one or more of IL-10, IL-12p(70), G-CSF, IL-9, VEGF, CD206, IL-1rα

, IL-13, IL-15, IL-17, CD4/294, CD11c/14, CD197/CD206, and DR(hi).

5. A computer-readable medium encoded with instructions that cause a programmable processor to:

receive time series data of immune variable concentration for an observed time period for each of a plurality of identified immune variables;

fit a periodic function to the time series data corresponding to each of the plurality of identified immune variables;

define a relative concentration of the fitted periodic function based on a maximum immune variable concentration within the observed time period, a minimum immune variable concentration within the observed time period, and an extrapolated immune variable concentration on a proposed treatment date;

define a relative derivative of the fitted periodic function based on a maximum derivative within the observed time period, a minimum derivative within the same period, and an extrapolated derivative on the proposed treatment date;

calculate a treatment prediction parameter based on the relative concentration and the relative differential;

choose the proposed treatment date such that the treatment prediction parameter is maximized; and

report the proposed date of treatment that maximizes the treatment prediction parameter.

6. A system comprising:

a controller that receives a set of time series data of immune variable concentration for an observed time period for each of a plurality of identified immune variables;

a curve-fitting module executed by the controller that fits a periodic function to the set of time series data corresponding to each of the plurality of identified immune variables;

a treatment prediction parameter module executed by the controller that calculates a treatment prediction parameter based on a relative concentration and a relative differential of the periodic function for each set of time series data that fits a periodic function;

a proposed treatment date module executed by the controller that chooses the proposed treatment date such that the treatment prediction parameter is maximized; and

a reporting module executed by the controller that generates a report concerning the proposed date of treatment that maximizes the treatment prediction parameter.

7. The system of claim 6, wherein the treatment prediction module further:

defines the relative concentration of the fitted periodic function based on a maximum immune variable concentration within the observed time period, a minimum immune variable concentration within the observed time period, and an extrapolated immune variable concentration on a proposed treatment date; and

defines the relative derivative of the fitted periodic function based on a maximum derivative within the observed time period, a minimum derivative within the same period, and an extrapolated derivative on the proposed treatment date.

8. A method comprising:

receiving a plurality of time series data of immune variable concentration in a patient for an observed time period each corresponding to a different one a plurality of identified immune variables;

determining for which of the identified immune variables the corresponding time series of immune variable concentration fit a periodic function;

for those immune variables that fit a periodic function, defining a relative concentration of the fitted periodic function based on a maximum immune variable concentration within the observed time period, a minimum immune variable concentration within the observed time period, and an extrapolated immune variable concentration on a proposed treatment date;

for those immune variables that fit a periodic function, defining a relative derivative of the fitted periodic function based on a maximum derivative within the observed time period, a minimum derivative within the same period, and an extrapolated derivative on the proposed treatment date;

calculating a treatment prediction parameter based on the relative concentration and the relative differential;

choosing the proposed treatment date such that the treatment prediction parameter is maximized; and

reporting the proposed date of treatment for the patient that maximizes the treatment prediction parameter.

9. The method of claim 8 wherein calculating a treatment prediction parameter based on the relative concentration and the relative differential comprises calculating a parameter Pi (Π

) according to the equation;

Π

=e<sup>der×

T</sup>×

e^conc, where

der is the relative derivative,

conc is the relative concentration, and

T is a function period in days to correct for variable period length.

10. The method of claim 8 wherein calculating a treatment prediction parameter based on the relative concentration and the relative differential comprises calculating a parameter Pi (Π

) according to the equation;

Π

=(der×

T)+conc, where

der is the relative derivative,

conc is the relative concentration, and

T is a function period in days to correct for variable period length.

11. The method of claim 8 wherein determining for which of the identified immune variables the corresponding time series of immune variable concentration fit a periodic function comprises determining which if the identified immune variables that corresponding time series fit a logistic function, a quadratic function, a cosine function, a rational function, a Gaussian function, or a Morgan-Mercer-Flodin (MMF) function.

12. A method of determining one or more favorable treatment times for delivery of pharmacological treatment to a patient, comprising:

receiving a set of time series data for each of one or more biological variables;

determining whether each set of time series data fit a periodic function;

for each biological variable that fits a periodic function, computing a treatment prediction parameter; and

determining one or more favorable treatment times based on the treatment prediction parameter calculated for at least one of the biological variables that fits a periodic function.

13. The method of claim 12 wherein receiving a set of time series data for each of one or more biological variables comprises receiving a set of time series data for one or more immune variables.

14. The method of claim 12 receiving a set of time series data for each of one or more biological variables comprises receiving a set of time series data for one or more of IL-10, IL-12p(70), G-CSF, IL-9, VEGF, CD206, IL-1rα

, IL-13, IL-15, IL-17, CD4/294, CD11c/14, CD197/CD206, and DR(hi).

15. The method of claim 12 wherein determining whether each set of time series data fit a periodic function comprises determining whether each set of time series data fit a cosine function.

16. The method of claim 12 further comprising determining a best fit periodic function for each of the biological parameters.

17. The method according to claim 16, wherein computing a treatment prediction parameter comprises computing a treatment prediction parameter based on the relative concentration of the biological variable and the relative derivative of the best fit periodic function.

18. The method of claim 12 further comprising, for each biological variable that fits a periodic function, determining a relative concentration of the periodic function based on a maximum immune variable concentration within an observed time period, a minimum immune variable concentration within the observed time period, and an extrapolated immune variable concentration on a proposed treatment date.

19. The method of claim 12 further comprising, for each biological variable that fits a periodic function, determining a relative derivative of the periodic function based on a maximum derivative within an observed time period and a minimum derivative within the observed time period, and an extrapolated derivative on a proposed treatment date.